Core Viewpoint - Guangyu Group reported a significant decline in revenue and a record net loss for 2024, primarily due to the deep adjustment in the real estate market, declining project gross margins, and substantial asset impairment provisions [1][2]. Financial Performance - The company achieved an operating revenue of 4.65 billion yuan in 2024, a decrease of 49.62% compared to 9.23 billion yuan in 2023 [2]. - The net profit attributable to shareholders was -1.01 billion yuan, a dramatic drop of 2754.19% from a profit of 38 million yuan in 2023 [2]. - The cash flow from operating activities was 600 million yuan, down 61.15% from 1.55 billion yuan in the previous year [2]. - Basic and diluted earnings per share were both -1.3033 yuan, compared to 0.0491 yuan in 2023, marking a decrease of 2754.38% [2]. - The total assets at the end of 2024 were approximately 10 billion yuan, a decline of 28.89% from 14.06 billion yuan in 2023 [2]. Business Segments - The real estate development segment generated revenue of 2.29 billion yuan, a 63.82% decrease year-on-year, accounting for 49.32% of total revenue [2]. - Sales performance of key projects in Shaoxing, Hangzhou, and Huangshan fell short of expectations, leading to declines in both settlement amounts and gross margins [2]. - The trading segment reported revenue of 2.10 billion yuan, down 20.40%, failing to offset the downturn in the real estate business [2]. Asset Impairment - The company recognized impairment provisions of 939 million yuan for assets showing signs of impairment, directly impacting net profit by 774 million yuan [3]. - Major contributors to the impairment included inventory write-downs, investment property, and fixed asset impairments [3]. Strategic Shift - In response to industry changes, Guangyu Group is accelerating its transition to the silver-haired care industry, with its Anuo New Journey International Care Center achieving a rapid increase in occupancy rates [3]. - The company completed over 600 home modifications for elderly care in Zhejiang Province in 2024 and received qualifications for managing elderly care institutions in Hangzhou [3]. - In early 2025, Guangyu Group plans to invest an additional 500 million yuan into the silver-haired care platform to enhance its integrated medical and care service capabilities [3]. - The chairman emphasized a dual-driven strategy of "real estate + silver-haired care," focusing on current housing sales and precise marketing to accelerate inventory turnover while improving care service competitiveness through a Japanese care system and smart assistive devices [3].

Group 1 - The real estate sector in both Hong Kong and A-shares experienced a significant rally on May 7, with notable stock price increases for companies such as Jin Hui Holdings (up 21.9%) and Zhongliang Holdings (up 7.06%) [1] - The People's Bank of China announced a 0.5 percentage point reserve requirement ratio cut, expected to inject approximately 1 trillion yuan into the market, along with a 0.1 percentage point reduction in policy interest rates [2] - The reduction in personal housing provident fund loan rates by 0.25 percentage points is projected to save residents over 20 billion yuan annually in interest, supporting rigid housing demand and stabilizing the real estate market [2] Group 2 - Following the "May Day" holiday, there was a surge in property subscriptions in various cities, with Shenzhen seeing a 23.89% year-on-year increase in new housing subscriptions during the holiday [3] - The introduction of high-quality projects in major cities like Beijing, Shanghai, and Hangzhou is expected to stimulate demand for improved housing and facilitate market recovery in May [3] - Major financial institutions are increasingly optimistic about the Chinese real estate market, with reports indicating a favorable policy environment and potential recovery in core cities [3]

广宇集团股份有限公司 关于回购公司股份的进展公告 证券代码：002133 证券简称：广宇集团 公告编号：(2025)033 广宇集团股份有限公司关于回购公司股份的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 根据《上市公司股份回购规则》《深圳证券交易所上市公司自律监管指引第 9 号——回购股份》的相关规定，公司应当在回购期间每个月的前三个交易日内 披露截至上月末的回购进展情况。现将公司回购进展情况公告如下： 截至 2025 年 4 月 30 日，公司尚未实施股份回购。 公司后续将在回购期限内根据市场情况实施本次回购，并根据有关规定及时 履行信息披露义务，敬请广大投资者注意投资风险。 特此公告。 广宇集团股份有限公司董事会 2025 年 5 月 7 日 广宇集团股份有限公司（以下简称"公司"）于 2025 年 4 月 3 日召开的第 七届董事会第二十七次会议、第七届监事会第十六次会议和于 2025 年 4 月 22 日召开的 2025 年第二次临时股东大会审议通过《关于回购公司股份方案的议 案》。使用自有资金和自筹资金以集中竞价交易方式通过深圳证券交 ...

前十大流通股东累计持有： 29234.05万股，累计占流通股比： 37.97%，较上期变化： 250.25万股。 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.0493 | 0.0043 | -1246.51 | 0.1078 | | 每股净资产（元） | 3.71 | 5.12 | -27.54 | 5.25 | | 每股公积金(元) | 1.09 | 1.09 | 0 | 1.09 | | 每股未分配利润(元) | 1.25 | 2.67 | -53.18 | 2.80 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 8.67 | 13.43 | -35.44 | 16.82 | | 净利润(亿元) | -0.38 | 0.03 | -1366.67 | 0.83 | | 净资产收益率(%) | -1.32 | 0.08 | -1750 | 2.07 | 数据四舍五入，查看更多财务数据>> 二、前10 ...

Financial Performance - The company's revenue for Q1 2025 was ¥865,458,115.95, a decrease of 35.48% compared to ¥1,341,350,963.33 in the same period last year[3] - The net profit attributable to shareholders was -¥38,161,346.94, representing a decline of 1,233.24% from ¥3,367,456.76 year-on-year[3] - The basic and diluted earnings per share were both -¥0.0493, a decrease of 1,246.51% from ¥0.0043 in the same period last year[3] - The company reported a net profit of -36,737,808.93 yuan for the current period, compared to a net profit of 35,551,817.51 yuan in the previous period, indicating a significant decline[27] - Basic and diluted earnings per share for the current period were -0.0493, compared to 0.0043 in the previous period[30] - The company experienced a decrease in sales revenue from 1,197,431,675.76 yuan to 845,939,686.30 yuan, reflecting a decline in business activity[31] - The company reported a total profit of -32,955,321.24 yuan, compared to 59,916,427.22 yuan in the previous period, indicating a substantial loss[27] Cash Flow and Liquidity - The net cash flow from operating activities improved to ¥72,112,375.92, a significant increase of 131.24% compared to -¥230,833,359.94 in the previous year[3] - Cash flow from operating activities generated a net cash inflow of 72,112,375.92 yuan, a recovery from a net outflow of -230,833,359.94 yuan in the previous period[31] - Total cash and cash equivalents at the end of the period were 1,017,992,455.11 yuan, down from 1,577,351,765.80 yuan in the previous period[34] - Cash and cash equivalents decreased to CNY 1,255,935,284.96 from CNY 1,505,507,093.78, representing a decline of 16.5%[19] - Cash flow from financing activities resulted in a net outflow of -379,716,871.58 yuan, compared to -94,682,600.91 yuan in the previous period[34] - The company received cash from the issuance of shares amounting to 980,000.00 yuan, an increase from 735,000.00 yuan in the previous period[34] Assets and Liabilities - Total assets at the end of the reporting period were ¥9,322,556,920.31, down 6.74% from ¥9,996,074,864.67 at the end of the previous year[3] - Total assets decreased to CNY 9,322,556,920.31 from CNY 9,996,074,864.67, a reduction of 6.8%[21] - Total liabilities decreased to CNY 6,266,842,171.86 from CNY 6,867,177,307.29, a decline of 8.7%[23] - The equity attributable to shareholders decreased by 1.31% to ¥2,873,905,274.20 from ¥2,912,066,621.14 at the end of the last year[3] Operational Insights - The company reported a significant decline in gross profit margin compared to the previous year, impacting net profit[7] - The company has not disclosed any new product developments or market expansion strategies in this report[3] - Total operating revenue for Q1 2025 was CNY 866,667,354.46, a decrease of 35.4% compared to CNY 1,342,549,712.13 in the same period last year[25] - Total operating costs for Q1 2025 were CNY 910,149,375.43, down 32.3% from CNY 1,344,689,015.87 year-over-year[25] - Inventory as of March 31, 2025, was CNY 5,380,585,728.88, down 8.5% from CNY 5,884,723,784.10[19] Strategic Plans - The company plans to enhance cash flow management in its real estate business and expand its silver-haired health care business to create a second growth curve[15] - The company aims to actively conduct cash dividends based on its operational and financial conditions, enhancing investor confidence[15] - The company is committed to improving information disclosure quality and optimizing investor relations management[15] - The 2025 valuation enhancement plan focuses on core business and cost structure optimization to drive high-quality development[15] Non-Recurring Items - Non-recurring gains and losses totaled ¥1,428,699.01 for the reporting period[5] - The company incurred financial expenses of 24,709,220.21 yuan, an increase from 20,024,108.18 yuan in the previous period[27] - Investment activities generated a net cash inflow of 2,293,840.70 yuan, down from 57,891,883.96 yuan in the previous period[31]

广宇集团股份有限公司 2024年度 营业收入扣除情况表的鉴证报告 关于广宇集团股份有限公司 2024年度营业收入扣除情况表的鉴证报告 信会师报字[2025]第ZF10559号 广宇集团股份有限公司全体股东： 我们审计了广宇集团股份有限公司(以下简称"广宇集团")2024 年度的财务报表，包括 2024 年 12 月 31 日的合并及母公司资产负债 表、2024 年度合并及母公司利润表、合并及母公司现金流量表、合 并及母公司所有者权益变动表和相关财务报表附注，并于 2025 年 4 月 24 日出具了报告号为信会师报字[2025]第 ZF10556 号的无保留意 见审计报告。 在对上述财务报表执行审计的基础上，我们接受委托，对后附的 广宇集团2024年度营业收入扣除情况表（以下简称"营业收入扣除情 况表"）执行了合理保证的鉴证业务。 一、管理层的责任 广宇集团管理层的责任是按照《深圳证券交易所股票上市规则》 和《深圳证券交易所上市公司自律监管指南第1号——业务办理》的 相关规定编制营业收入扣除情况表，确保营业收入扣除情况表真实、 准确、完整，不存在虚假记载、误导性陈述或重大遗漏。 二、注册会计师的责任 我们的责 ...

广宇集团股份有限公司 独立董事述职报告 广宇集团股份有限公司 独立董事 2024 年度述职报告 各位股东、股东代表： 作为广宇集团股份有限公司（以下简称"公司"）的独立董事，本人在 2024 年度，严格按照《公司法》《证券法》《上市公司独立董事规则》等法律法规和《公 司章程》的要求，忠实、勤勉、尽职地履行了独立董事的职责。不受公司大股东、 实际控制人以及其他与公司存在利害关系的单位与个人的影响，积极出席公司股 东大会和董事会，发挥个人专长，对公司的日常经营和发展提出意见和建议。充 分发挥了独立监督的作用，切实维护公司和全体股东尤其是中小股东的利益。现 将本人 2024 年度履职情况汇报如下： 一、参加会议情况 1、参加董事会情况 公司董事会在 2024 年度共召开会议 10 次，本人均亲自出席，没有委托出席 或缺席的情况。对于所出席的各次董事会会议，本着勤勉务实、诚信负责的态度， 就提交董事会审议的议案均事先进行了认真的审核，在阅读会议材料、客观判断 市场形势和公司实际的基础上，本人对审议的各项议案及相关事项均未提出异议。 2、参加股东大会情况 2024 年度，公司召开了 3 次股东大会，本人均亲自出席。 三 ...

根据证监会《上市公司独立董事管理办法》、深圳证券交易所《股票上市规 则》《深圳证券交易所上市公司自律监管指引第 1 号—主板上市公司规范运作》 等要求，广宇集团股份有限公司（以下简称"公司"）董事会，就公司在任独立 董事贾生华、姚铮、王小毅的独立性情况进行评估并出具如下专项意见： 经核查独立董事贾生华、姚铮、王小毅的任职经历以及签署的相关自查文件， 上述人员未在公司担任除独立董事以外的任何职务，也未在公司主要股东公司担 任任何职务，与公司以及主要股东之间不存在利害关系或其他可能妨碍其进行独 立客观判断的关系。因此，公司独立董事符合《上市公司独立董事管理办法》等 相关文件中对独立董事独立性的相关要求。 广宇集团股份有限公司董事会 2025 年 4 月 26 日 广宇集团股份有限公司 董事会关于独立董事独立性情况的专项意见 广宇集团股份有限公司 董事会关于独立董事独立性情况的 专项意见 ...

广宇集团股份有限公司 独立董事述职报告 公司董事会在 2024 年度共召开 10 次会议，本人均亲自出席，没有委托出席 或缺席的情况。对于所出席的各次董事会会议，本着勤勉务实、诚信负责的态度， 就提交董事会审议的议案均事先进行了认真的审核，在阅读会议材料、客观判断 市场形势和公司实际的基础上，本人对审议的各项议案及相关事项均未提出异议。 广宇集团股份有限公司 独立董事 2024 年度述职报告 各位股东、股东代表： 作为广宇集团股份有限公司（以下简称"公司"）的独立董事，本人在 2024 年度，严格按照《公司法》《证券法》《上市公司独立董事规则》等法律法规和 《公司章程》的要求，忠实、勤勉、尽职地履行了独立董事的职责。不受公司大 股东、实际控制人以及其他与公司存在利害关系的单位与个人的影响，积极出席 公司股东大会和董事会，发挥个人专长，对公司的日常经营和发展提出意见和建 议。充分发挥了独立监督的作用，切实维护公司和全体股东尤其是中小股东的利 益。现将本人 2024 年度履职情况汇报如下： 一、参加会议情况 1、参加董事会情况 2、参加股东大会情况 2024 年度，公司召开了 3 次股东大会，本人均亲自出席。 3 ...

各位股东、股东代表： 作为广宇集团股份有限公司（以下简称"公司"）的独立董事，本人在 2024 年度，严格按照《公司法》《证券法》《上市公司独立董事规则》等法律法规和《公 司章程》的要求，忠实、勤勉、尽职地履行了独立董事的职责。不受公司大股东、 实际控制人以及其他与公司存在利害关系的单位与个人的影响，积极出席公司股 东大会和董事会，发挥个人专长，对公司的日常经营和发展提出意见和建议。充 分发挥了独立监督的作用，切实维护公司和全体股东尤其是中小股东的利益。现 将本人 2024 年度履职情况汇报如下： 一、参加会议情况 1、参加董事会情况 广宇集团股份有限公司 独立董事述职报告 广宇集团股份有限公司 独立董事 2024 年度述职报告 公司董事会在 2024 年度共召开 10 次会议，本人均亲自出席，没有委托出席 或缺席的情况。对于所出席的各次董事会会议，本着勤勉务实、诚信负责的态度， 就提交董事会审议的议案均事先进行了认真的审核，在阅读会议材料、客观判断 市场形势和公司实际的基础上，本人对审议的各项议案及相关事项均未提出异议。 2、参加股东大会情况 2024 年度，公司召开了 3 次股东大会，本人均亲自出席。 3 ...